Interleukin 28 is a potential therapeutic target for sepsis.

This study defines IL-28 as a detrimental mediator during sepsis and identifies a potential therapeutic target for the immune therapy in sepsis.

Source: Current Awareness Service for Health (CASH) - June 19, 2019 Category: Consumer Health News Source Type: news